Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature-Reference-Cited by-同舟云学术

Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature

Published:2023-02-20 Issue:6 Volume:68 Page:2604-2623
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Berinstein Elliot M.,Sheehan Jessica L,Jacob Janson,Steiner Calen A.,Stidham Ryan W.,Shannon Carol,Bishu Shrinivas,Levine Jake,Cohen-Mekelburg Shirley A.,Waljee Akbar K.,Higgins Peter D. R.,Berinstein Jeffrey A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-023-07837-0.pdf

Reference44 articles.

1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. Nov2009;361(21):2066–2078. https://doi.org/10.1056/NEJMra0804647.

2. Reinink AR, Lee TC, Higgins PD. Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis. Inflamm Bowel Dis. 22(8):1859–69. https://doi.org/10.1097/MIB.0000000000000816

3. Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141(4):1194–1201. https://doi.org/10.1053/j.gastro.2011.06.054.

4. Peyrin-Biroulet L, Lémann M. Review article: remission rates achievable by current therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33(8):870–879. https://doi.org/10.1111/j.1365-2036.2011.04599.x.

5. Colombel JF, Sandborn WJ, Reinisch W et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;362(15):1383–1395. https://doi.org/10.1056/NEJMoa0904492.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis;Expert Review of Gastroenterology & Hepatology;2024-08-28

2. Efficacy and Safety of Sphingosine 1-Phosphate Receptor Modulators for Ulcerative Colitis;Journal of Clinical Gastroenterology;2024-08-08

3. Axial spondyloarthritis and inflammatory bowel disease: Therapeutic implications;Joint Bone Spine;2024-07

4. Combination treatment of inflammatory bowel disease: Present status and future perspectives;World Journal of Gastroenterology;2024-04-21

5. Disease clearance in ulcerative colitis: A new therapeutic target for the future;World Journal of Gastroenterology;2024-04-07